Zoetis K9 Para (4/5/2022)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} {{webinarsregistrationpage::race_approved}} true 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Zoetis {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

Macrocyclic lactones are currently the only drug family available for heartworm prevention in the United States. Areas of the country that have not historically reported heartworm cases are now more frequently testing and recognizing increased case numbers, and they are higher in endemic areas, despite the broad availability of heartworm preventives for decades. In addition to the increasing prevalence, there is also the issue of macrocyclic lactone-resistant heartworms, all of which we will explore in this presentation.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} An introduction to macrocyclic lactones The difference among lack of efficacy claims, poor compliance, and drug resistance Current updates on drug resistance in heartworm disease The areas of drug resistance in the US What you need to know for your patients {{webinarsregistrationpage::what_youll_learn_bullet_6}} {{webinarsregistrationpage::additional_subhead}} {{webinarsregistrationpage::additional_copy}} In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.